Category: Joint ventures/collaborations
-
Institute, Company Studying Neuro Disease Proteins
The Montreal Neurological Institute and Thermo Fisher Scientific are beginning a study of 30 proteins implicated in neurodegenerative diseases to validate related antibodies and reagents for advancing treatments.
-
Biotech Sponsoring Microbiome-Cancer Research
A biotechnology enterprise is starting research collaborations with cancer labs in the U.S. and Germany to study interactions of gut microbes on responses of individuals to cancer immunotherapies.
-
Trials Test Antibodies to Prevent Hospital Infections
Clinical trials are underway in the U.S. as part of a larger international project testing synthetic antibodies designed to prevent infections from bacteria often found in hospitals and clinics.
-
Coalition Standardizes Chronic Kidney Disease Tests
A group of medical lab companies, medical centers, and not-for-profit groups developed standardized testing protocols for chronic kidney disease, which participants expect will help more people diagnose the condition earlier.
-
Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal
Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease.
-
Gut Tissue From Stem Cells Simulated on Organ Chips
Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients.
-
Biotechs Collaborate on Immunotherapies in $1.2B Deal
Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers.
-
Smart Thermometer Data Speed Flu Forecasting
Data collected from electronic thermometers are shown by researchers to track and report the spread of influenza cases in the U.S. faster than federal health authorities, as well as provide more up-to-date forecasts.
-
Open-Source Discovery Seeks Neglected Disease Drug
An international online collaboration is using an open process to discover new drug compounds to treat mycetoma, a slow-progressing inflammatory fungal disease occurring mainly in developing regions, which up to now is largely neglected.
-
Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s
A biotechnology company specializing in stem cell therapeutics is licensing a process from Texas A&M University to produce exosomes — cellular delivery packages — from adult stem cells as possible therapies for Alzheimer’s disease.